1. Yoon, Hyun Ju, Kim, Gi-Cheon, Oh, Sejin, Kwon, Ho-Keun, Kim, Hyun Seok. 2022. WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function. In Experimental & molecular medicine, 54, 1913-1926. doi:10.1038/s12276-022-00876-z. https://pubmed.ncbi.nlm.nih.gov/36357569/
2. Lee, A-Young, Chen, Wei, Stippec, Steve, Juang, Yu-Chi, Cobb, Melanie H. 2012. Protein kinase WNK3 regulates the neuronal splicing factor Fox-1. In Proceedings of the National Academy of Sciences of the United States of America, 109, 16841-6. doi:10.1073/pnas.1215406109. https://pubmed.ncbi.nlm.nih.gov/23027929/
3. Cruz-Rangel, Silvia, Melo, Zesergio, Vázquez, Norma, Gamba, Gerardo, Mercado, Adriana. 2011. Similar effects of all WNK3 variants on SLC12 cotransporters. In American journal of physiology. Cell physiology, 301, C601-8. doi:10.1152/ajpcell.00070.2011. https://pubmed.ncbi.nlm.nih.gov/21613606/
4. Glover, Mark, Zuber, Annie Mercier, O'Shaughnessy, Kevin M. 2009. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression. In Journal of the American Society of Nephrology : JASN, 20, 1314-22. doi:10.1681/ASN.2008050542. https://pubmed.ncbi.nlm.nih.gov/19470686/